Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | oxyphenbutazone | 4641 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | oxyphenbutazone | 4641 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | nomegestrol | 68783 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | nomegestrol | 68783 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | nomegestrol | 68783 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nomegestrol | 68783 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | nomegestrol | 68783 | drug-path |
Glioma | Q9NZM4 | map05214 | nomegestrol | 68783 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | nomegestrol | 68783 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | nomegestrol | 68783 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | nomegestrol | 68783 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | nomegestrol | 68783 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | nomegestrol | 68783 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | nomegestrol | 68783 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | nomegestrol | 68783 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | nomegestrol | 68783 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | nomegestrol | 68783 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | nomegestrol | 68783 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | ifenprodil | 3689 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | ifenprodil | 3689 | drug-path |